NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Developmental Delay Could Stem From Nicotinic Receptor Deletion

    Wednesday, November 11, 2009

    Houston -- The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine in a report that appears online today in the journal Nature Genetics.

    read more>>

  • 0%
    0 votes

    Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms

    Thursday, October 29, 2009

    BLOOMINGTON, Minn. -- The Child Neurology Foundation (CNF) today announced that $30,000 was raised during Infantile Spasms Awareness Week (October 11-17) that will go towards researching the cause and treatment of this ultra-rare form of epilepsy.

    read more>>

  • 0%
    0 votes

    Epilepsy Drugs Could Treat Alzheimer's and Parkinson's

    Wednesday, October 28, 2009

    Researchers in the USA have discovered a potential new function for anti-epileptic drugs in treating neurodegenerative disorders such as Alzheimer's and Parkinson's disease. The study, published in BioMed Central's open access journal Molecular Neurodegeneration, found that neurons in the brain were protected after treatment with T-type calcium-channel blockers, which are commonly used to treat…

    read more>>

  • 0%
    0 votes

    Benefit for Natalie' Will Aid Child

    Thursday, October 22, 2009

    A"Benefit for Natalie" will be held Oct. 24 from 3 to 7 p.m. at the Headliner in Neptune. The event will be an afternoon of fun for the entire family.Natalie is the 4-year-old daughter of a 13-year veteran of the Howell Police Department who has suffered from seizures since birth.

    read more>>

  • 0%
    0 votes

    'Benefit for Natalie' Will Aid Child

    Wednesday, October 14, 2009

    A "Benefit for Natalie" will be held on Oct. 24 from 3-7 p.m. at the Headliner in Neptune. The event will be an afternoon of fun for the entire family.Natalie is the 4-year-old daughter of a 13- year veteran of the Howell Police Department. She has had seizures since birth.At 4 months old, Natalie was diagnosed with infantile spasms, a rare seizure disorder. This requires Natalie to…

    read more>>

  • 0%
    0 votes

    Johnstown Teen Gains Support in Fight Against Rare Disease

    Thursday, October 1, 2009

    When Jessica Ambroe of Johnstown was diagnosed with Lafora disease in February, it allowed her family and friends to put a name to the affliction they had struggled with for more than a year.They found that the former straight-A honors student was now battling a rare and fatal neurological epilepsy that is currently afflicting fewer than a dozen people in the United States.

    read more>>

  • 0%
    0 votes

    Nursing Students Raise Money for Teenager With Rare Disease

    Tuesday, September 29, 2009

    JOHNSTOWN, Pa. -- A group of nursing students are making a difference by helping a Johnstown girl battle a rare disease.Lafora disease is a rare form of epilepsy. Only 200 kids worldwide are diagnosed with the disease, with only 10 known cases in the United States.Jessica Ambroe was diagnosed with Lafora in February. Jessica, 15, used to be a cheerleader at Ferndale High School. Earlier this year…

    read more>>

  • 0%
    0 votes

    Gene Mutation Causes Severe Epilepsy, Febrile Seizures in Thousands of Infants Worldwide

    Thursday, September 17, 2009

    SALT LAKE CITY — University of Utah medical researchers have identified a gene with mutations that cause febrile seizures and contribute to a severe form of epilepsy known as Dravet syndrome in some of the most vulnerable patients – infants 6 months and younger.

    read more>>

  • 0%
    0 votes

    Lundbeck's Epilepsy Med Approved, J&J's Rejected

    Tuesday, August 25, 2009

    Shares of Lundbeck are on the rise today on the news that the FDA has approved the drugmaker's anti-epilepsy drug Sabril. The drug, which received the FDA nod as a monotherapy on Friday, is the first approved for the treatment of infantile spasms in children aged one month to two years. Infantile spasms is a rare disease that causes hundreds of spasms per day and kills as many as 20 percent of…

    read more>>

  • 0%
    0 votes

    Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures

    Monday, August 24, 2009

    Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United States approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months. The disorder can be…

    read more>>